药物对比
Fremanezumab vs Rizatriptan
Compare Fremanezumab (Ajovy) vs Rizatriptan (Maxalt): CGRP mAb for migraine prevention vs triptan for acute attacks. Both Rx, no black box.
此页面暂无可用的对比维度。
临床背景
This comparison arises when choosing between CGRP monoclonal antibody prophylaxis and triptan abortive therapy for migraine.
结论
Fremanezumab suits migraine prevention while Rizatriptan is better for acute attack treatment.
全部药物对比